KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,185,000 | +37.7% | 39,953 | -20.6% | 0.02% | +21.4% |
| Q2 2017 | $5,218,000 | +27.8% | 50,339 | -3.3% | 0.01% | +27.3% |
| Q1 2017 | $4,084,000 | +50.0% | 52,030 | -14.3% | 0.01% | +37.5% |
| Q4 2016 | $2,723,000 | -28.1% | 60,720 | -10.5% | 0.01% | -33.3% |
| Q3 2016 | $3,788,000 | +7.6% | 67,809 | -3.6% | 0.01% | +9.1% |
| Q2 2016 | $3,519,000 | +1.6% | 70,372 | -6.7% | 0.01% | 0.0% |
| Q1 2016 | $3,464,000 | -43.1% | 75,449 | -23.7% | 0.01% | -38.9% |
| Q4 2015 | $6,093,000 | -15.2% | 98,884 | -23.3% | 0.02% | -18.2% |
| Q3 2015 | $7,183,000 | -18.9% | 128,999 | -11.2% | 0.02% | 0.0% |
| Q2 2015 | $8,855,000 | +20.2% | 145,232 | +13.7% | 0.02% | +29.4% |
| Q1 2015 | $7,368,000 | +40.6% | 127,737 | +40.6% | 0.02% | +30.8% |
| Q4 2014 | $5,241,000 | – | 90,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |